Simplifying the Bredesen Protocol

By Dr. Dale Bredesen | June 14, 2020 | Comments Off on Simplifying the Bredesen Protocol

By Julie Gregory, Chief Health Liaison for Apollo Health. Hi friends-“Summer’s here, and the living is easy.” But is it really? Especially for those who’ve recently begun practicing the protocol, it can sometimes feel pretty overwhelming. Your old way of eating and living often change pretty dramatically, depending upon your starting place. Even those that have been using the…

Read More

The Six Types of Alzheimer’s Disease

By Dr. Dale Bredesen | April 14, 2020 | Comments Off on The Six Types of Alzheimer’s Disease

Determining if you have Alzheimer’s disease does not help you to avoid it or reverse it. Instead, determining why you have Alzheimer’s is key to developing a treatment plan. As we have learned, there are at least 36 contributors to cognitive decline. Most people who already have Alzheimer’s disease or MCI (mild cognitive impairment, the harbinger of Alzheimer’s) or…

Read More

Reversal of Cognitive Decline In Alzheimer’s Disease

By Dr. Dale Bredesen | June 14, 2016 | Comments Off on Reversal of Cognitive Decline In Alzheimer’s Disease

AGING, June 2016, Vol. 8 No. 6 Abstract: Alzheimer’s disease is one of the most significant healthcare problems nationally and globally. Recently, the first description of the reversal of cognitive decline in patients with early Alzheimer’s disease or its precursors, MCI (mild cognitive impairment) and SCI (subjective cognitive impairment), was published [1]. The therapeutic approach…

Read More

Reversal of Cognitive Decline: A Novel Therapeutic Program

By Dr. Dale Bredesen | September 14, 2014 | Comments Off on Reversal of Cognitive Decline: A Novel Therapeutic Program

AGING, September 2014, Vol. 6 No. 9 Abstract: This report describes a novel, comprehensive, and personalized therapeutic program that is based on the underlying pathogenesis of Alzheimer’s disease, and which involves multiple modalities designed to achieve metabolic enhancement for neurodegeneration (MEND). The first 10 patients who have utilized this program include patients with memory loss…

Read More